Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefano Taddei
Evaluation of the Effect of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality of Patients With Chronic Heart Failure and a Reduced Ejection Fraction: Rationale for and Design of the EMPEROR‐Reduced Trial
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Inflammation and Not Cardiovascular Risk Factors Is Associated With Short Leukocyte Telomere Length in 13- To 16-Year-Old Adolescents
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Adipocytokine Levels Mark Endothelial Function in Normotensive Individuals
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Dapagliflozin Acutely Improves Endothelial Dysfunction, Reduces Aortic Stiffness and Renal Resistive Index in Type 2 Diabetic Patients: A Pilot Study
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Renal Resistive Index Predicts Post-Bariatric Surgery Renal Outcome in Nondiabetic Individuals With Severe Obesity
Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Adolescents With Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin
Journal of Pediatric and Adolescent Gynecology
Child Health
Gynecology
Perinatology
Obstetrics
Medicine
Pediatrics
Erratum To: Efficacy and Safety of Olmesartan Medoxomil 40 Mg/Hydrochlorothiazide 12.5 Mg Combination Therapy Versus Olmesartan Medoxomil 40 Mg Monotherapy in Patients With Moderate to Severe Hypertension
Clinical Drug Investigation
Medicine
Pharmacology
Endothelial Dysfunction in Hypertension: Pathophysiological Mechanism or Marker of Cardiovascular Risk?
Italian Journal of Medicine
Medicine
Effect of Sulfaphenazole on Tissue Plasminogen Activator Release in Normotensive Subjects and Hypertensive Patients
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Cyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential Hypertension
Hypertension
Internal Medicine